A molecular diagnostics company focused on genomic profiling tests that help identify targeted treatment options for cancer patients. Its sequencing-based assays are used by oncologists and biopharma companies to guide therapy decisions and support drug development, including companion diagnostics t...
No congressional trades have been disclosed for Foundation Medicine, Inc. (FMI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.